Patients switching from Wegovy to orforglipron had a change of -0.1 kg versus a 9.4 kg gain for placebo
Product Specifications Product Name: Mounjaro Tirzepatide Injection Active Ingredient: Tirzepatide Strength: 15 mg Dosage Form: Injection Therapeutic Category: GLP-1 & GIP Receptor Agonist / Antidiabetic Agent Packaging: Standard Manufacturer Packaging Storage Conditions: Refrigerate at 2C to 8C
Since starting with their program, I've lost 85 pounds and gained so much more than just weight loss
Hidden health issues that make weight loss harder
It lists a personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2, severe gastroparesis, and acute kidney injury as making semaglutide inappropriate
Interestingly, this raises important points in regard to the need to hold GLP-1 RAs prior to concurrent EGD and colonoscopy procedures and the number of days needed to hold these agents, if necessary